This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
USANA Health Sciences (USNA) Tops Q2 Earnings Estimates
by Zacks Equity Research
USANA Health (USNA) delivered earnings and revenue surprises of 10.92% and -3.29%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
Zoetis (ZTS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Momentum Stocks to Buy for July 21st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 21st
Explore 5 Top-Ranked Stocks Through DuPont Analysis
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
USANA (USNA) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
USANA (USNA) will release second-quarter 2020 results, which are likely to reflect impacts of the COVID-19 pandemic.
Will USANA Health Sciences Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of USANA Health Sciences
New Strong Buy Stocks For July 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (USNA) Outperforming Other Medical Stocks This Year?
USANA Health Sciences (USNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AbbVie (ABBV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 DuPont-Tested Winning Stocks
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.
Pacira (PCRX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Pacira (PCRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International
by Zacks Equity Research
Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International
Power Your Portfolio With These 4 Top-Ranked Liquid Gems
by Zacks Equity Research
Here are four excellent liquid stocks, including Fortinet (FTNT), that can contribute to making an outstanding portfolio for yield-seeking investors.
New Strong Buy Stocks for June 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
New Strong Buy Stocks for June 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
DuPont: A Less-Traversed Path to Pick 5 Winning Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
New Strong Buy Stocks For June 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
USANA Health Sciences (USNA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
USANA Health (USNA) delivered earnings and revenue surprises of 115.79% and 20.97%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: USANA Health Sciences, Semler Scientific, EMCOR Group, Vipshop and Renewable Energy Group
by Zacks Equity Research
Zacks.com featured highlights include: USANA Health Sciences, Semler Scientific, EMCOR Group, Vipshop and Renewable Energy Group
Have Faith in DuPont Analysis & Pick These 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? If you do, bet on these five stocks.
Earnings Preview: USANA Health Sciences (USNA) Q1 Earnings Expected to Decline
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 DuPont-Tested Winning Stocks
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.
Zacks.com featured highlights include: USANA Health Sciences, EMCOR, Vipshop and Renewable Energy
by Zacks Equity Research
Zacks.com featured highlights include: USANA Health Sciences, EMCOR, Vipshop and Renewable Energy